Study to Evaluate the Response to Treatment and Safety of 0.03% Tacrolimus (FK506) Ointment Administered in Pediatric Patients With Moderate to Severe Atopic Dermatitis
Clinical trial NCT00691262 · COMPLETED
Trial details
- NCT number
- NCT00691262
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-10-01
- Primary completion
- 2005-02-01
- Enrollment
- 166
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.